Enteral yeast-selenium supplementation in preterm infants
a National Institute of Rheumatology and
Physiotherapy, Budapest, Hungary, b Nutrition
Laboratory, National Public Health Institute of Finland, Helsinki,
Finland, c 1st Department of Obstetrics and
Gynecology, Perinatal Intensive Centre, Semmelwies Medical School,
Budapest, Hungary, d Perinatal
Intensive Care, Schöpf-Mérei Ágost Hospital, Budapest, Hungary
Correspondence to: Dr Gábor Bogye, 1027 Budapest, Frankel Leó u. 7., Hungary.
Accepted 26 November 1997
AIM
To study the bioavailability of selenium
enriched yeast in preterm infants living in a low selenium area (Hungary).
METHODS
Thirty six preterm infants were
randomly assigned to two groups at birth with respect to selenium
supplementation. In the supplemented group (n=18) infants received 4.8 mg of selenium enriched yeast containing 5 µg selenium daily.
RESULTS
In the supplemented group the serum
selenium concentration increased from 36.1(±12.8) µg/l to 43.5 (7.9) µg/l and in the non-supplemented group it decreased from 34.4 (20.4) µg/l to 26.1 (16.6) µg/l from birth in two weeks. No
complications or side effects as a result of supplementation were observed.
CONCLUSIONS
Selenium enriched yeast is a
safe and an effective form of short term enteral selenium
supplementation for preterm infants.
© 1998 by Archives of Disease in Childhood
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.



